Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin as Adjuvant Therapy for Symptomatic Non-complicated UTI
NCT02094703Phase 4Unknown
- Sponsor
- Dr. Cipto Mangunkusumo Hospital
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in urinary tract infection (UTI), sponsored by Dr. Cipto Mangunkusumo Hospital. Status: unknown.
02
Drugs
solifenacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02094703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094703.